Quadrivalent influenza vaccine (Sinovac Biotech) for seasonal influenza prophylaxis

Authors:

Abstract
Quadrivalent Influenza Vaccine (Sinovac Biotech) is a quadrivalent split-virion-inactivated influenza vaccine approved in China in June 2020 for individuals ≥3 years of age. It contains 15 µg hemag...
Funding Information
  • the National Major Scientific and Technological Special Project of China

This publication has 47 references indexed in Scilit: